Chinese Journal of Nephrology, Dialysis & Transplantation ›› 2026, Vol. 35 ›› Issue (2): 190-194.DOI: 10.3969/j.issn.1006⁃298X.2026.02.018
Previous Articles Next Articles
Online:
Published:
Abstract: A 17⁃year⁃old male patient presented with nephrotic syndrome.Renal biopsy revealed extensive foot process effacement (>90%) and cytoplasmic phagolysosomes in glomerular podocytes under the electron microscope,indicating a diagnosis of minimal change disease (MCD).Despite 8 weeks of full⁃dose corticosteroids,the patient exhibited persistent massive proteinuria,indicating steroid⁃resistant MCD.Serological testing revealed positive anti⁃nephrin antibody with a titer of 1∶30.After treatment with obinutuzumab (1g infusions for 2 doses),the patient achieved rapid remission of proteinuria and negative conversion of anti⁃nephrin IgG antibody.Corticosteroids were successfully tapered and discontinued over 5 months.Sustained remission of nephrotic syndrome has been achieved with obinutuzumab (1g) as maintenance therapy.
LIU Moyuan, TU Yuanmao, WANG Jingjing, LIU Zhihong, CHENG Zhen. Obinutuzumab treatment for steroid⁃resistant minimal change disease[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2026, 35(2): 190-194.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.njcndt.com/EN/10.3969/j.issn.1006⁃298X.2026.02.018
http://www.njcndt.com/EN/Y2026/V35/I2/190